High-Dose Recombinant Interleukin-18 Induces an Effective Th1 Immune Response to Murine MOPC-315 Plasmacytoma-Reference-Cited by-同舟云学术

High-Dose Recombinant Interleukin-18 Induces an Effective Th1 Immune Response to Murine MOPC-315 Plasmacytoma

Published:2002-03 Issue: Volume:25 Page:S20-S27
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Jonak Zdenka L.,Trulli Stephen,Maier Curtis,McCabe Francis L.,Kirkpatrick Robert,Johanson Kyung,Ho Yen Sen,Elefante Louis,Chen Yi-Jiun,Herzyk Danuta,Lotze Michael T.,Johnson Randall K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference37 articles.

1. Cytokines in cancer therapy

2. Cloning of a new cytokine that induces IFN-γ production by T cells

3. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock

4. Interleukin-18: A Novel Cytokine That Augments Both Innate and Acquired Immunity

5. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioengineering strategies to enhance the interleukin-18 bioactivity in the modern toolbox of cancer immunotherapy;Cytokine & Growth Factor Reviews;2023-09

2. The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation;The Journal of Antibiotics;2021-07-12

3. Cellular Therapy for Melanoma;Cutaneous Melanoma;2020

4. Cellular Therapy for Melanoma;Cutaneous Melanoma;2018-10-26

5. Th1 cytokine-based immunotherapy for cancer;Hepatobiliary & Pancreatic Diseases International;2014-10